DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Chi G, Gibson CM, Kalayci A. , et al.
Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy.
Intensive Care Med 2019;
45 (04) 477-487
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.